Captopril attenuates diuretic and natriuretic actions of furosemide but not atrial natriuretic peptide
Version 2 2024-06-17, 13:43Version 2 2024-06-17, 13:43
Version 1 1987-01-01, 00:00Version 1 1987-01-01, 00:00
journal contribution
posted on 2024-06-17, 13:43 authored by RD Nicolantonio, TO MorganAtrial Natriuretic Peptide (ANP) exerts a potent diuretic and natriuretic action in rat, dog and man. To test whether these actions of ANP are due to antagonism of the antinatriuretic actions of endogenous angiotensin II, an examination was made of the renal actions of ANP in anesthetized rats with and without captopril pretreatment. Captopril treatment did not alter the diuretic and natriuretic action of a single, intravenous bolus injection of ANP (1000 ng of the 8-33 ANP). Captopril treatment did significantly attenuate the diuretic and natriuretic actions of Furosemide (20 mg/kg ip). This attenuation was not reversed by concomitant, exogenous angiotensin II infusion. These results suggest that while ANP exerts its renal actions independently of the circulating renin-angiotensin system the diuretic and natriuretic action of Furosemide is modulated by a substrate of angiotensin converting enzyme. © 1987 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
History
Related Materials
- 1.
Language
engPublication classification
CN.1 Other journal articleJournal
Clinical and Experimental Hypertension (Informa)Volume
A9Pagination
19-32ISSN
1064-1963Issue
1Publisher
Taylor & FrancisUsage metrics
Keywords
Licence
Exports
RefWorksRefWorks
BibTeXBibTeX
Ref. managerRef. manager
EndnoteEndnote
DataCiteDataCite
NLMNLM
DCDC

